Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
1811 participants
INTERVENTIONAL
2011-05-31
2013-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Mass Treatment T Solium Community Study
NCT00138359
A Pilot Study of Neurocysticercosis Treatment
NCT00283699
Compassionate Use of Triclabendazole for the Treatment of Parasites (Prior to FDA Approval; Expanded Access Program)
NCT01931085
The Effect of a Deworming Intervention to Improve Early Childhood Growth and Development in Resource-poor Areas
NCT01314937
Monitoring the Efficacy of Anthelmintics for the Treatment of Soil Transmitted Helminths P2
NCT01379326
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
SCREENING
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Targeted screening
Screening for intestinal tapeworm carrier followed by treatment with niclosamide as indicated.
Niclosamide
Single oral dose of niclosamide determined by weight (dose: 11 to 34kg receive 1 gram, 35 to 50kg receive 1.5 grams, over 50kg receive 2 grams)
Education
Community education about Taenia solium prevention.
Community education campaign
Education about prevention of Taenia solium infection provided in a single short (20 minute) interaction with the participant. Education was verbal with visual aids.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Niclosamide
Single oral dose of niclosamide determined by weight (dose: 11 to 34kg receive 1 gram, 35 to 50kg receive 1.5 grams, over 50kg receive 2 grams)
Community education campaign
Education about prevention of Taenia solium infection provided in a single short (20 minute) interaction with the participant. Education was verbal with visual aids.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National University of San Marcos, Peru
OTHER
National Institute of Neurological Disorders and Stroke (NINDS)
NIH
Oregon Health and Science University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Seth E O'Neal, MD MPH
Assistant professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Seth E ONeal, MD MPH
Role: PRINCIPAL_INVESTIGATOR
Oregon Health and Science University
Armando Gonzalez, DVM PhD
Role: PRINCIPAL_INVESTIGATOR
San Marcos University School of Veterinary Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
San Marcos University
Lima, , Peru
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.